<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>
    <!-- Font Awesome -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.9.0/css/all.min.css"
        integrity="sha512-q3eWabyZPc1XTCmF+8/LuE1ozpg5xxn7iO89yfSOd5/oKvyqLngoNGsx8jq92Y8eXJ/IRxQbEC+FGSYxtk2oiw=="
        crossorigin="anonymous" referrerpolicy="no-referrer" />
    <!-- Bootstrap CSS -->
    <link rel="stylesheet" href="css/bootstrap.min.css">
    <!-- Custom CSS -->
    <link rel="stylesheet" href="css/style.min.css">
</head>

<body class="">

    <div class="main_page5 fixedHeight position-relative">
        <div class="nav_orange">
            <div class="nav_orange_left">
                <h4 class="GothamBook mb-0">MM1: Ixazomib (NINLARO) + Rd was studied in a broad range <br> of patients with RRMM, including patients with high-risk <br> cytogenetics<sup>1–3</sup></h4>
            </div>
            <div class="nav_orange_right">
                <img src="img/logo_orange.png" alt="">
            </div>
        </div>
        <!-- page 5 middle box -->
            <div class="page5_middle_box page21_middle_box mt-3 mb-4">
                <div class="page21_middle_left">
                    <div>
                        <h4 class="txt_orange GothamBook mt-5 mb-2 pt-2 yellowBorderTop">TOURMALINE-MM1 CLINICAL TRIAL</h4>
                        <h5 class="page21_blue GothamBlack" style="padding: 10px;">BASELINE PATIENT CHARACTERISTICS<sup>1,2</sup></h5>
                    </div>
                    <div class="p9_table pt-2">
                        <div class="border_top_orange_1 d-flex align-items-center justify-content-between text-end py-1 pe-4">
                            <div class="w-50"></div>
                            <div class="w-25 txt_orange GothamBlack text-center">Ixazomib <br> (NINLARO) + Rd <br> <span class="GothamMedium">n=360</span></div>
                            <div class="w-25 txt_silver GothamBlack text-center">Placebo + Rd <br> <span class="GothamMedium">n=362</span></div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow">
                            <div class="w-50 text-start txt_blue GothamBlack">Median age</div>
                            <div class="w-25 text-center txt_orange GothamBlack">66 years</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">66 years</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow">
                            <div class="w-50 text-start txt_blue GothamBlack">Male/female</div>
                            <div class="w-25 text-center txt_orange GothamBlack">58%/42%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">56%/44%</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow table_td_bg_blue_imp">
                            <div class="w-50 text-start txt_blue GothamMedium">1 prior therapy*</div>
                            <div class="w-25 text-center txt_orange GothamBlack">62%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">60%</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow table_td_bg_blue_imp">
                            <div class="w-50 text-start txt_blue GothamMedium">2 or 3 prior therapies*</div>
                            <div class="w-25 text-center txt_orange GothamBlack">38%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">40%</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow table_td_bg_blue_imp">
                            <div class="w-50 text-start txt_blue GothamMedium">Prior PI*†</div>
                            <div class="w-25 text-center txt_orange GothamBlack">69%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">70%</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow">
                            <div class="w-50 text-start txt_blue GothamBlack">Prior IMiD†</div>
                            <div class="w-25 text-center txt_orange GothamBlack">54%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">56%</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow">
                            <div class="w-50 text-start txt_blue GothamBlack">Prior stem cell transplant</div>
                            <div class="w-25 text-center txt_orange GothamBlack">59%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">55%</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow">
                            <div class="w-50 text-start txt_blue GothamBlack">Relapsed</div>
                            <div class="w-25 text-center txt_orange GothamBlack">77%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">77%</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow">
                            <div class="w-50 text-start txt_blue GothamBlack">Refractory‡</div>
                            <div class="w-25 text-center txt_orange GothamBlack">12%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">11%</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow">
                            <div class="w-50 text-start txt_blue GothamMedium">Relapsed and refractory</div>
                            <div class="w-25 text-center txt_orange GothamBlack">11%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">12%</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow table_td_bg_blue_imp">
                            <div class="w-50 text-start txt_blue GothamMedium">High-risk cytogenetics§</div>
                            <div class="w-25 text-center txt_orange GothamBlack">21%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">17%</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow">
                            <div class="w-50 text-start txt_blue GothamMedium">ISS stage I or II*</div>
                            <div class="w-25 text-center txt_orange GothamBlack">88%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">88%</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow">
                            <div class="w-50 text-start txt_blue GothamMedium">ISS stage III*</div>
                            <div class="w-25 text-center txt_orange GothamBlack">12%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">12%</div>
                        </div>

                        <div class="d-flex align-items-center justify-content-between py-1 pe-4 p9_table_nrow table_td_bg_blue_imp">
                            <div class="w-50 text-start txt_blue GothamMedium">Creatinine clearance &lt;60 mL/min</div>
                            <div class="w-25 text-center txt_orange GothamBlack">22%</div>
                            <div class="w-25 text-center txt_silver GothamBlack text-center">27%</div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="page21_middle_right">
                <div class="page21_blue_box mb-4">
                    <p class="mb-0 pe-4 fs-12">Clinical laboratory evaluations for high-risk <br> cytogenetic markers, including del(17p), t(4;14), and <br> t(14;16), were performed by a central laboratory<sup>3</sup></p>
                </div>
                <div class="page21_blue_box">
                    <p class="mb-0 pe-4 fs-12">Positivity for del(17p) was defined by a <br> percentage of positive cells that were above <br> the technical background cut-off of 5%<sup>3</sup></p>
                </div>
            </div>
            <div class="px-4 mx-4" style="margin-top: 90px;">
                <p class="GothamLight fs_7">*Stratification factor. †A patient who received both a prior PI and a prior IMiD would count for both categories. ‡
                    Primary refractory, defined as patients that were refractory to all lines of previous treatment(s) <br>
                    (i.e., patients who have never responded to any therapies received), was documented in 7% and 6% of patients in the ixazomib and placebo regimens, respectively. Patients refractory to PIs or lenalidomide <br>
                    were excluded.1,2 §Defined as patients with del(17p), t(4;14), or t(14;16).3 REVLIMID® is a registered trademark of Celgene Corporation. IMiD = immunomodulatory drug; ISS = International Staging System; <br>
                    MM = multiple myeloma; PI = proteasome inhibitor; Rd = REVLIMID® (lenalidomide) + dexamethasone; RRMM = relapsed/refractory multiple myeloma.</p>
            </div>
    </div>
        <!--  -->

            <div class="footer_page5">
                <div class="d-flex align-items-end">
                    <div class="page5_btns_md">
                        <a href="../page5/index.html"><p class="mb-0 position-relative">MM1 study design</p></a>
                        <a href="../page6/index.html"><p class="mb-0 position-relative">MM1 patient baseline characteristics</p></a>
                        <a href="../page8/index.html"><p class="mb-0 position-relative">RWE study Hajek et al.</p></a>
                        <a href="../page15/index.html"><p class="mb-0 position-relative">RWE study Terpos et al.</p></a>
                        <a href="../page11/index.html"><p class="mb-0 position-relative">RWE study Chari et al.</p></a>
                        <a href="../page18/index.html"><p class="mb-0 position-relative">RWE study Minarik et al.</p></a>
                        <a href="../page21/index.html"><p class="mb-0 position-relative">MM1 PFS</p></a>
                        <a href="../page23/index.html"><p class="mb-0 position-relative">MM1 PFS in patients with high-risk cytogenetics</p></a>
                        <a href="../page25/index.html"><p class="mb-0 position-relative">MM1 response rate</p></a>
                        <a href="../page28/index.html"><p class="mb-0 position-relative">MM1 PFS in <br> pre-treated patients</p></a>
                        <a href="../page31/index.html"><p class="mb-0 position-relative">MM1 safety data</p></a>
                        <a href="../page34/index.html"><p class="mb-0 position-relative">Dosing</p></a>
                        <a href="../page36/index.html"><p class="mb-0 position-relative">Summary</p></a>
                        <a href="../page38/index.html"><p class="mb-0 position-relative">MM6 data</p></a>
                        <a></a>
                    </div>
                    <div class="footer_inner_nav1 position-static ms-auto bg-transparent p-0">
                        <ul>
                            <li>
                                <a href="../page4/index.html"><img src="img/page_1_footer_icon_1.svg" alt=""></a>
                            </li>
                            <li>
                                <a href="https://onetakeda.app.box.com/s/reg7tviee8telgupc6cccshjet2wqqqh" target="_blank" class="text-uppercase">pi</a>
                            </li>
                            <li>
                                <a href="../page7/index.html" class="text-uppercase">ref</a>
                            </li>
                        </ul>
                    </div>
                </div>
            </div>
    </div>

</body>

</html>